Ignite Creation Date:
2025-12-24 @ 4:03 PM
Ignite Modification Date:
2026-02-20 @ 10:43 PM
Study NCT ID:
NCT01458366
Status:
COMPLETED
Last Update Posted:
2025-04-30
First Post:
2011-09-26
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase I/II Study of Bendamustine in Combination With Ofatumumab, Carboplatin and Etoposide
Sponsor:
Sidney Kimmel Cancer Center at Thomas Jefferson University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-11-09
Start Date Type:
ACTUAL
Primary Completion Date:
2018-08-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-07-23
Completion Date Type:
ACTUAL
First Submit Date:
2011-09-26
First Submit QC Date:
None
Study First Post Date:
2011-10-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-08-27
Results First Submit QC Date:
None
Results First Post Date:
2020-03-24
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-28
Last Update Post Date:
2025-04-30
Last Update Post Date Type:
ACTUAL